For the year ending 2025-12-31, SXTP has $5,366,211 in assets. $1,986,795 in debts. $1,510,065 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 1,510,065 | |||
| Accounts receivable | 509,644 | |||
| Prepaid and other assets | 978,131 | |||
| Short-term investments | 1,240,721 | |||
| Inventory (note 3) | 656,924 | |||
| Total current assets | 4,895,485 | |||
| Property and equipment, net (note 4) | 246,365 | |||
| Long-term prepaid expense | 0 | |||
| Intangible assets, net (note 5) | 224,361 | |||
| Total other assets | 224,361 | |||
| Total assets | 5,366,211 | |||
| Accounts payable and accrued expenses | 1,459,279 | |||
| Sba eidl (including accrued interest) (note 7) | 8,772 | |||
| Derivative liabilities (note 8) | 374,741 | |||
| Total current liabilities | 1,842,792 | |||
| Sba eidl (including accrued interest) (note 7) | 144,003 | |||
| Total long-term liabilities | 144,003 | |||
| Total liabilities | 1,986,795 | |||
| Series a preferred stock, 0.0001 par value, 1,000,000 shares authorized 76,480 and 76,480 issued and outstanding as of december 31, 2025 and december 31, 2024, respectively (note 6) | 9,567,439 | |||
| Common stock, 0.0001 par value, 150,000,000 shares authorized 1,163,142 and 141,749 issued and outstanding as of december 31, 2025 and december 31, 2024, respectively (note 6) | 116 | |||
| Additional paid-in capital | 41,646,139 | |||
| Accumulated other comprehensive income | 142,598 | |||
| Accumulated deficit | -47,893,115 | |||
| 60p shareholders equity | 3,463,177 | |||
| Noncontrolling interest | -83,761 | |||
| Total shareholders equity | 3,379,416 | |||
| Total liabilities and shareholders equity | 5,366,211 | |||
60 DEGREES PHARMACEUTICALS, INC. (SXTP)
60 DEGREES PHARMACEUTICALS, INC. (SXTP)